CLC bio

CLC bio (now QIAGEN Digital Insights) was a bioinformatics software company specializing in solutions for data analysis in genomics, transcriptomics, and proteomics. Founded in Aarhus, Denmark, CLC bio developed a range of software tools primarily targeted at researchers in molecular biology, genetics, and related fields.

The company's flagship product, the CLC Genomics Workbench, provided a graphical user interface (GUI) based platform for a variety of bioinformatics tasks, including next-generation sequencing (NGS) data analysis, sequence alignment, phylogenetic analysis, and protein structure prediction. Other software offerings included solutions for clinical genomics, drug discovery, and microbiome research.

CLC bio aimed to provide user-friendly, integrated software solutions for handling and interpreting complex biological data. This focus made their software accessible to researchers with varying levels of computational expertise. The company was acquired by QIAGEN in 2013 and now operates as QIAGEN Digital Insights. The CLC Genomics Workbench and other related products are now part of QIAGEN's bioinformatics portfolio.